01.04.2002 | Original Article
A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients
Erschienen in: Supportive Care in Cancer | Ausgabe 3/2002
Einloggen, um Zugang zu erhalten